2022;34:299e3166
This work was supported by Integrated Chinese and Western Medicine (YC-2023-0404), Fudan Zhangjiang Clinical Medicine Innovation Fund Project (KP0202118), Fudan Good Practice Program of Teaching and Learning (FD2023A227), Project of Key Medical Discipline of Pudong Hospital of Fudan University (Zdxk2020-11), Project of Key Medical Specialty and Treatment Center of Pudong Hospital of Fudan University (Zdzk2020-24), Pudong New Area Clinical Plateau Discipline Project (PWYgy-2021-03), the Natural Science Foundation of China (21675034), National Natural Science Foundation of China (81370932), Shanghai Natural Science Foundation (19ZR1447500), Pudong New Area Clinical Characteristic Discipline Project (PWYts2021-11), Pudong New Area Clinical Characteristic Discipline Project (PWYts2021-01), Pudong Research Project (YC-2023-0202, YC-2023-0607, PWRI2023-08), Wenzhou Medical University Education Grant (JG2021197), Pudong Research Project (PWRl2023-08, YC-2023-0128
Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S -D-lactoylglutathione
HaavikJ.BlauN.ThnyB.2008Mutations in human monoamine-related neurotransmitter pathway genes.297(July 2008),891902,1059-7794 42
with adaptions explained in Wessling et al
